New Publication: VEGF-C and -D Signaling Pathways as Potential Targets for the Treatment of Wet AMD In this month’s edition of Ophthalmology and Therapy, a scientific review was published about the growing body of evidence that in retinal diseases, such as wet AMD, the pathophysiology is broader than simply dysregulation or overproduction of VEGF-A. Despite the tremendous progress in standard-of-care intravitreal anti-VEGF-A agents, visual gains can be limited in some wet AMD patients, as shown by clinical and real-world studies. We want to recognize and thank the authors; Ian Leitch Mike Gerometta David Eichenbaum Robert Finger Nathan Steinle Megan Baldwin To read full peer-review article: https://lnkd.in/eu2-_Bdt Christopher Vautrinot Springer Nature Group Springer Healthcare #Opthea #maculardegeneration #AMDResearch #wetAMD #ophthalmology #medicaleducation #biopharma #eyehealth #retinaspecialists #sozinibercept
Great article
Director of Research, Retina Vitreous Associates of Florida, Collaborative Associate Professor, Morsani College of Medicine at the University of South Florida
1moThank you! I’m proud to be part of this work 🙏